Elsevier, Drug and Alcohol Dependence, (163), p. 16-23, 2016
DOI: 10.1016/j.drugalcdep.2016.02.042
Full text: Download
Deaths from opioid overdose can be prevented through administration of the antagonist naloxone, which has been licensed for injection since the 1970s. To support wider availability of naloxone in community settings, novel non-injectable naloxone formulations are being developed, suitable for emergency use by non-medical personnel.